Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

HS Walter; S Jayne; SA Rule; G Cartron; F Morschhauser; S Macip; L Karlin; C Jones; C Herbaux; P Quittet; N Shah; CV Hutchinson; C Fegan; Y Yang; S Mitra; G Salles; MJS Dyer

doi:10.1182/blood-2017-02-765115

Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

HS Walter, S Jayne, SA Rule, G Cartron, F Morschhauser, S Macip, L Karlin, C Jones, C Herbaux, P Quittet, N Shah, CV Hutchinson, C Fegan, Y Yang, S Mitra, G Salles, MJS Dyer

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2808-2810
Number of pages	0
Journal	Blood
Volume	129
Issue number	20
DOIs	https://doi.org/10.1182/blood-2017-02-765115
Publication status	Published - 18 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2017-02-765115

Cite this

Walter, HS., Jayne, S., Rule, SA., Cartron, G., Morschhauser, F., Macip, S., Karlin, L., Jones, C., Herbaux, C., Quittet, P., Shah, N., Hutchinson, CV., Fegan, C., Yang, Y., Mitra, S., Salles, G., & Dyer, MJS. (2017). Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059. Blood, 129(20), 2808-2810. https://doi.org/10.1182/blood-2017-02-765115

@article{9c950616204e428e9a0ac86791db20a0,

title = "Long-term follow-up of patients with CLL treated with the selective Bruton{\textquoteright}s tyrosine kinase inhibitor ONO/GS-4059",

author = "HS Walter and S Jayne and SA Rule and G Cartron and F Morschhauser and S Macip and L Karlin and C Jones and C Herbaux and P Quittet and N Shah and CV Hutchinson and C Fegan and Y Yang and S Mitra and G Salles and MJS Dyer",

year = "2017",

month = may,

day = "18",

doi = "10.1182/blood-2017-02-765115",

language = "English",

volume = "129",

pages = "2808--2810",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "20",

}

Walter, HS, Jayne, S, Rule, SA, Cartron, G, Morschhauser, F, Macip, S, Karlin, L, Jones, C, Herbaux, C, Quittet, P, Shah, N, Hutchinson, CV, Fegan, C, Yang, Y, Mitra, S, Salles, G & Dyer, MJS 2017, 'Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059', Blood, vol. 129, no. 20, pp. 2808-2810. https://doi.org/10.1182/blood-2017-02-765115

TY - JOUR

T1 - Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

AU - Walter, HS

AU - Jayne, S

AU - Rule, SA

AU - Cartron, G

AU - Morschhauser, F

AU - Macip, S

AU - Karlin, L

AU - Jones, C

AU - Herbaux, C

AU - Quittet, P

AU - Shah, N

AU - Hutchinson, CV

AU - Fegan, C

AU - Yang, Y

AU - Mitra, S

AU - Salles, G

AU - Dyer, MJS

PY - 2017/5/18

Y1 - 2017/5/18

U2 - 10.1182/blood-2017-02-765115

DO - 10.1182/blood-2017-02-765115

M3 - Article

SN - 0006-4971

VL - 129

SP - 2808

EP - 2810

JO - Blood

JF - Blood

IS - 20

ER -